POU2AF1 and Buschke-Ollendorff syndrome: Our group previously reported a blood gene expression analysis in which we identified three genes, POU class 2 associating factor 1, T-cell leukaemia/lymphoma protein 1A and B-cell lymphocyte kinase, which were validated as predictive biomarkers of BOS more than 6 months before diagnosis [24].